The Drug Controller General of India (DCGI) on Sunday authorised Russia’s single-dose COVID-19 vaccine, Sputnik Lite, for emergency use in India.
Sputnik Lite thus turned the ninth COVID-19 vaccine within the nation to be authorised for the grownup inhabitants.
“This will further strengthen the nation’s collective fight against the pandemic,” Union Health Minister Mansukh Mandaviya stated in a tweet.
DCGI has allowed emergency use for the single-dose Sputnik Lite COVID-19 vaccine in India.
it is ninth #COVID-19 vaccine within the nation
This will additional strengthen the collective battle of the nation towards the pandemic.
— Dr. Mansukh Mandaviya (@mansukhmandviya) 6 February 2022
Sources stated the choice comes after the topic professional panel on vaccines advisable to the drug regulator that Emergency Use Authorization (EUA) be given to the single-dose Sputnik Lite vaccine.
Sputnik Lite, developed by Russia’s Gamalya Center, is constructed on the human adenovirus vector platform. In October final 12 months, the federal government had authorised the export of Sputnik Light, which is manufactured by Hetero Biopharma Ltd, in India.
Sputnik Lite is much like component-1 of the Russian Sputnik V vaccine that has been utilized in India’s vaccination marketing campaign.
India has given about 1.2 million doses of Sputnik V to the nation’s grownup inhabitants. The firm had earlier stated that the single-shot vaccine has demonstrated 70 % efficacy towards an infection by the delta variant of COVID-19.
“A preliminary study from the Gamalaya Center found that Sputnik Lite significantly increased virus neutralizing activity against Omicron based on sera 2-3 months after vaccination, compared with 100% of individuals treated with Sputnik Lite. Neutralizing antibodies have been developed against this type as a booster,” the Russian Direct Investment Fund had earlier stated.
,
With inputs from TheIndianEXPRESS
